TheProfitWatch

NAMS - NewAmsterdam Pharma Company N.V. Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
38.7 -1.04 (-2.69%) 0.04 (0.11%) 0.07 (0.19%) -0.09 (-0.23%) -0.9 (-2.33%) 0.01 (0.03%) 0.0 (0.0%) 0.0 (0.0%)

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.15
Diluted EPS:
-0.15
Basic P/E:
-251.0667
Diluted P/E:
-251.0667
RSI(14) 1m:
72.06
VWAP:
37.63
RVol:

Events

Period Kind Movement Occurred At

Related News